{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:29:57Z","timestamp":1790958597760,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.saa.2024.124731","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T16:08:15Z","timestamp":1719418095000},"page":"124731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["In-vivo pharmacokinetic study of ibrutinib-loaded nanostructured lipid carriers in rat plasma by sensitive spectrofluorimetric method using harmonized approach of quality by design and white analytical chemistry"],"prefix":"10.1016","volume":"321","author":[{"given":"Pintu","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneri","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veera Shakar","family":"Pulusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzarul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Abul","family":"Kalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2024.124731_b0005","article-title":"White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality","volume":"138","author":"Nowak","year":"2021","journal-title":"Trends Ana. Chem."},{"key":"10.1016\/j.saa.2024.124731_b0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jaoacint\/qsad108","article-title":"Simultaneous chromatographic estimation of vildagliptin and dapagliflozin using hybrid principles of white analytical chemistry and analytical quality by design","volume":"107","author":"Rana","year":"2024","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.saa.2024.124731_b0015","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s42250-023-00835-9","article-title":"Multipurpose RP-HPLC method for simultaneous estimation of fixed-dose combinations of anti-diabetic drugs: integrating green, economical, and robust approaches with design of experiments and white analytical chemistry","volume":"7","author":"Mishra","year":"2024","journal-title":"Chem. Africa"},{"key":"10.1016\/j.saa.2024.124731_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00764-023-00262-z","article-title":"Implementation of white analytical chemistry-driven analytical quality risk assessment and design of experiments to multipurpose chromatographic method for the synchronous estimation of multiple drugs co-formulated with paracetamol","volume":"37","author":"Salunkhe","year":"2024","journal-title":"J. Planar Chromat."},{"key":"10.1016\/j.saa.2024.124731_b0025","unstructured":"International Council for Harmonization, Q3C (R8) guideline, Impurities: a guideline for residual solvent, 2016, 1-40."},{"key":"10.1016\/j.saa.2024.124731_b0030","unstructured":"Indian Pharmacopoeia, Volume I, Residual Solvents, the Indian Pharmacopeia Commission, 2018, 987."},{"key":"10.1016\/j.saa.2024.124731_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40508-016-0051-z","article-title":"Tools and techniques for solvent selection: green solvent selection guides","volume":"4","author":"Byrne","year":"2016","journal-title":"Sustain. Chem. Process."},{"key":"10.1016\/j.saa.2024.124731_b0040","first-page":"1","article-title":"Implementation of white analytical chemistry\u2013assisted analytical quality by design approach to green liquid chromatographic method for concomitant analysis of anti-hypertensive drugs in human plasma","author":"Prajapati","year":"2013","journal-title":"J. Chromat. Sci."},{"key":"10.1016\/j.saa.2024.124731_b0045","doi-asserted-by":"crossref","first-page":"2300332","DOI":"10.1002\/jssc.202300332","volume":"46","author":"Prajapati","year":"2023","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.saa.2024.124731_b0050","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/jaoacint\/qsad082","article-title":"Principles of white analytical chemistry and design of experiments to stability-indicating chromatographic method for simultaneous estimation of thiocolchicoside and lornoxicam","volume":"106","author":"Prajapati","year":"2023","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.saa.2024.124731_b0055","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/chromsci\/bmad057","article-title":"Analytical Quality Risk Assessment and Design of Experiments to Green HPTLC Method for Simultaneous Estimation of Sildenafil Citrate and Dapoxetine Hydrochloride","volume":"62","author":"Prajapati","year":"2023","journal-title":"J. Chromat. Sci."},{"key":"10.1016\/j.saa.2024.124731_b0060","unstructured":"Drug data bank for Ibrutinib, https:\/\/go.drugbank.com\/drugs\/DB09053, accessed on 2nd August 2023."},{"key":"10.1016\/j.saa.2024.124731_b0065","first-page":"189","article-title":"Estimation of ibrutinib in dosage form and in bulk drug by UV spectrophotometric and colourimetric methods","volume":"15","author":"Sultana","year":"2022","journal-title":"Asian J. Res. Chem."},{"key":"10.1016\/j.saa.2024.124731_b0070","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10812-022-01367-9","article-title":"Development and Validation of a Sensitive Spectrofluorimetric Method for the Determination of Ibrutinib","volume":"89","author":"Mondal","year":"2022","journal-title":"J. Appl. Spectroscopy"},{"key":"10.1016\/j.saa.2024.124731_b0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/sscp.202100063","article-title":"Development and validation of liquid chromatography method for determination of Ibrutinib in finished dosage forms using quality by design approach","volume":"5","author":"Konduru","year":"2022","journal-title":"J. Sep. Sci. plus"},{"key":"10.1016\/j.saa.2024.124731_b0080","doi-asserted-by":"crossref","first-page":"e4435","DOI":"10.1002\/bmc.4435","article-title":"Simple determination of plasma ibrutinib concentration using high-performance liquid chromatography","volume":"33","author":"Yasu","year":"2019","journal-title":"Biomed. Chromat."},{"key":"10.1016\/j.saa.2024.124731_b0085","first-page":"130","article-title":"A simple HPLC method for the determination of Ibrutinib in rabbit plasma and its application to a pharmacokinetic study","volume":"35","author":"Wei","year":"2016","journal-title":"Latin American J. Pharm."},{"key":"10.1016\/j.saa.2024.124731_b0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jchromb.2018.05.011","article-title":"Bioanalysis of ibrutinib, and its dihydrodiol-and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry","volume":"1090","author":"Rood","year":"2018","journal-title":"J. Chromat. B"},{"key":"10.1016\/j.saa.2024.124731_b0095","doi-asserted-by":"crossref","first-page":"e4703","DOI":"10.1002\/bmc.4703","article-title":"A rapid and sensitive method for quantification of ibrutinib in rat plasma by UPLC\u2013ESI\u2013MS\/MS: validation and application to pharmacokinetic studies of a novel ibrutinib nanocrystalline","volume":"34","author":"Sun","year":"2020","journal-title":"Biomed. Chromat."},{"key":"10.1016\/j.saa.2024.124731_b0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.5740\/jaoacint.15-0222","article-title":"Simple and sensitive UPLC-MS\/MS method for high-throughput analysis of ibrutinib in rat plasma: optimization by Box-Behnken experimental design","volume":"99","author":"Iqbal","year":"2016","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.saa.2024.124731_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113768","article-title":"LC and LC\u2013MS\/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway","volume":"194","author":"Mehta","year":"2021","journal-title":"J. Pharma. Biomed. Anal."},{"key":"10.1016\/j.saa.2024.124731_b0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpba.2014.11.041","article-title":"Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC\u2013MS\/MS: Application to a pharmacokinetic study","volume":"107","author":"Veeraraghavan","year":"2015","journal-title":"J. Pharma. Biomed. Anal."},{"key":"10.1016\/j.saa.2024.124731_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jpba.2015.10.033","article-title":"Liquid chromatography\u2013tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies","volume":"118","author":"Rood","year":"2016","journal-title":"J. Pharma. Biomed. Anal."},{"key":"10.1016\/j.saa.2024.124731_b0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jchromb.2018.06.026","article-title":"Development and validation of an UHPLC-MS\/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid","volume":"1093","author":"Beauvais","year":"2018","journal-title":"J. Chromatography B"},{"key":"10.1016\/j.saa.2024.124731_b0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/sscp.202100018","article-title":"Thin layer chromatographic method for separation and estimation of anticancer drug Ibrutinib in presence of its degradants","volume":"4","author":"Shah","year":"2021","journal-title":"Sep. Sci. plus"},{"key":"10.1016\/j.saa.2024.124731_b0130","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1039\/C9AN00861F","article-title":"A selective and robust UPLC-MS\/MS method for the simultaneous quantitative determination of anlotinib, ceritinib and ibrutinib in rat plasma and its application to a pharmacokinetic study","volume":"144","author":"Du","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.saa.2024.124731_b0135","doi-asserted-by":"crossref","first-page":"e4507","DOI":"10.1002\/bmc.4507","article-title":"The effect of naringenin on the pharmacokinetics of ibrutinib in rat: A drug\u2013drug interaction study","volume":"33","author":"Liu","year":"2019","journal-title":"Biomed. Chromat."},{"key":"10.1016\/j.saa.2024.124731_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1524-7","article-title":"Fabrication of ibrutinib nanosuspension by quality by design approach: intended for enhanced oral bioavailability and diminished fast fed variability","volume":"20","author":"Rangaraj","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.saa.2024.124731_b0145","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/jphp.12550","article-title":"Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system","volume":"68","author":"Shakeel","year":"2016","journal-title":"J. Pharmacy Pharmacol."},{"key":"10.1016\/j.saa.2024.124731_b0150","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014Analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.saa.2024.124731_b0155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: green analytical procedure index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2024.124731_b0160","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/cr068359e","article-title":"Green analytical methodologies","volume":"107","author":"Keith","year":"2007","journal-title":"Chem. Rev."},{"key":"10.1016\/j.saa.2024.124731_b0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical Eco-Scale for assessing the greenness of analytical procedures","volume":"37","author":"Ga\u0142uszka","year":"2012","journal-title":"TrAC Trends in Ana. Chem."},{"key":"10.1016\/j.saa.2024.124731_b0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/D0AY02169E","article-title":"Comparative study of four greenness assessment tools for selection of greenest analytical method for assay of hyoscine N-butyl bromide","volume":"13","author":"Gamal","year":"2021","journal-title":"Ana. Methods"},{"key":"10.1016\/j.saa.2024.124731_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2022.107242","article-title":"Environmental impact of the reported chromatographic methods for the determination of the first FDA-Approved therapy for COVID-19 Patients, Remdesivir: A comparative study","volume":"176","author":"Ahmed","year":"2022","journal-title":"Microchemical J."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142524008977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142524008977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T08:38:07Z","timestamp":1724575087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142524008977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"alternative-id":["S1386142524008977"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2024.124731","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vivo pharmacokinetic study of ibrutinib-loaded nanostructured lipid carriers in rat plasma by sensitive spectrofluorimetric method using harmonized approach of quality by design and white analytical chemistry","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2024.124731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124731"}}